UCRF Archives - UNC Lineberger Comprehensive Cancer Center

Jeremy R. Wang, PhD, and colleagues have created a new way for oncologists to more sensitively detect genetic mutations in B-cell acute lymphoblastic leukemia (B-ALL), the most common type of pediatric cancer.

Radiologist showing tomography scan of a patient's lungs over of CT machine.

To better understand the burdens of false-positive lung cancer screenings and ways to mitigate them, the NCI awarded UNC Lineberger researchers a $3.2 million grant to identify the potential harms of false-positive results at the patient, clinician, and facility levels.

Collage of images including a researcher looking at a data dashboard on a computer, along with images from the North Carolina cancer data dashboard.

UNC Lineberger has launched a resource for downloadable, shareable, and aggregated health data, which will help researchers, policymakers and healthcare providers better respond to concerning cancer trends and health needs throughout the state.

Group shot of UNC Lineberger Community Advisory Board members.

UNC Lineberger’s Community Advisory Board works to make sure cancer research reflects community needs across the state, and to raise public awareness of cancer’s signs and symptoms.

Patients using smartphones, tablets and laptops to report symptoms.

Digital reporting technologies created by UNC Lineberger researchers are now being used in North Carolina and across the country to improve care and outcomes for cancer patients.

UNC Lineberger's Lisa Carey and Chuck Perou.

UNC Lineberger researchers are leading next-generation clinical breast cancer trials as part of a national project using cutting-edge technologies to track tumor changes in real time.

Chad Pecot, MD, and Kristina Whately, PhD, work in the Pecot Lab.

Chad Pecot, MD, leads cancer RNA research at UNC Lineberger, creating innovative therapies and promising treatment strategies for multiple cancer mutations.

Single strand ribonucleic acid, RNA research and therapy.

Chad Pecot, MD, and colleagues have demonstrated that a uniquely engineered drug that zeroes in on a mutated gene called KRAS G12V could potentially stop KRAS-dependent cancers in their tracks.

Michael Emanuele, PhD, and colleagues have discovered that an enzyme called USP37 plays a crucial role in ensuring our cells copy their DNA correctly.

Ewing's sarcoma that has metastasized to the pleura fluid.

Pengda Liu, PhD, and colleagues have created a small molecule that targets and breaks down a protein linked to Ewing sarcoma, an aggressive cancer that mostly affects children and teens.

Tag: UCRF

UNC researchers develop faster, low-cost method to diagnose common pediatric cancer

Investigating approaches to make lung cancer screening more effective

“Data for everyone”: A new cancer dashboard launches at UNC Lineberger Comprehensive Cancer Center

Community Advisory Board engages NC communities in the fight against cancer

Building tools to help doctors better track patient symptoms, improve outcomes

UNC Lineberger continues its national leadership in breast cancer research

‘If you’re trying to make a difference in cancer, you can’t go slow’

Uniquely engineered KRAS-targeted cancer drug found to be effective in early studies

UNC researchers discover an enzyme that protects DNA during rapid cell divisions

Researchers develop molecule that targets Ewing sarcoma